Sini San ameliorates CCl4-induced liver fibrosis in mice by inhibiting AKT-mediated hepatocyte apoptosis
- 1 March 2023
- journal article
- research article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 303, 115965
- https://doi.org/10.1016/j.jep.2022.115965
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China
- Anhui Provincial Natural Science Foundation
- Major Science and Technology Projects in Anhui Province
This publication has 44 references indexed in Scilit:
- Protocol for Isolation of Primary Human Hepatocytes and Corresponding Major Populations of Non-parenchymal Liver CellsJournal of Visualized Experiments, 2016
- Liver Bid suppression for treatment of fibrosis associated with non-alcoholic steatohepatitisJournal of Hepatology, 2015
- The Chinese medicine Sini-San inhibits HBx-induced migration and invasiveness of human hepatocellular carcinoma cellsBMC Complementary and Alternative Medicine, 2015
- Helium preconditioning protects mouse liver against ischemia and reperfusion injury through the PI3K/Akt pathwayJournal of Hepatology, 2014
- Death receptors as targets in cancerBritish Journal of Pharmacology, 2013
- Evolving therapies for liver fibrosisJCI Insight, 2013
- Protective effect of Fufang-Liu-Yue-Qing, a traditional Chinese herbal formula, on CCl4 induced liver fibrosis in ratsJournal of Ethnopharmacology, 2012
- Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in ratsGut, 2011
- Hepatocyte Death: A Clear and Present DangerPhysiological Reviews, 2010
- Tumour necrosis factor signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in miceGut, 2006